Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral May/19/2021 26 7
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/24/2021 7 2
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021 4 0
Taxifolin Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020 2 0
GD1-69 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
Luminol sodium salt Potential treatment - pre-clinical evidence Experimental Antiviral Nov/20/2020 1 0
Prednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/14/2020 4 0